Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity

Promising phase II clinical results have been reported recently for several oncolytic viral therapeutics, including strains based on vaccinia virus. One reason for this has been an increased appreciation of the critical therapeutic importance of the immune response raised by these viruses. However,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Li, Jun, O'Malley, Mark, Sampath, Padma, Kalinski, Pawel, Bartlett, David L, Thorne, Steve H
פורמט: Artigo
שפה:Inglês
יצא לאור: Neoplasia Press Inc. 2012
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3540938/
https://ncbi.nlm.nih.gov/pubmed/23308044
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים